← Every applicant
Avet Lifesciences FDA Approvals
14 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| DOXYCYCLINE HYCLATENew drugFeb 19, 2026INJECTABLE, INJECTION |
| DIPHENHYDRAMINE HYDROCHLORIDENew drugNov 14, 2025INJECTABLE, INJECTION |
| DIPHENHYDRAMINE HYDROCHLORIDENew drugJun 24, 2025INJECTABLE, INJECTION |
| AMPHOTERICIN BNew drugJun 2, 2025INJECTABLE, LIPOSOMAL, INJECTION |
| MELPHALAN HYDROCHLORIDENew drugOct 29, 2024INJECTABLE, INJECTION |
| IBUTILIDE FUMARATENew drugApr 1, 2024INJECTABLE, INJECTION |
| FOSCARNET SODIUMNew drugJun 5, 2023SOLUTION, INTRAVENOUS |
| PHENYLEPHRINE HYDROCHLORIDENew drugFeb 28, 2023SOLUTION, INTRAVENOUS |
| NEOSTIGMINE METHYLSULFATENew drugNov 25, 2022SOLUTION, INTRAVENOUS |
| SODIUM NITROPRUSSIDENew drugNov 8, 2022INJECTABLE, INJECTION |
| ISOPROTERENOL HYDROCHLORIDENew drugNov 19, 2021INJECTABLE, INJECTION |
| PROPOFOLNew drugOct 12, 2021INJECTABLE, INJECTION |
| PALONOSETRON HYDROCHLORIDENew drugJun 29, 2021INJECTABLE, INTRAVENOUS |
| PENTAMIDINE ISETHIONATENew drugJan 7, 2021INJECTABLE, INJECTION |